Soleus Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9M Sell
1,029,252
-941,612
-48% -$36.8M 1.86% 14
2026
Q1
$69.7M Buy
1,970,864
+648,500
+49% +$20.1M 2.82% 9
2025
Q4
$37M Buy
+1,322,364
New +$39.6M 1.36% 20
2023
Q4
Sell
-54,400
Closed -$1.52M 75
2023
Q3
$1.52M Sell
54,400
-140,000
-72% -$4.1M 0.14% 74
2023
Q2
$6.08M Sell
194,400
-35,600
-15% -$1.08M 0.68% 43
2023
Q1
$6.48M Buy
+230,000
New +$6.27M 0.67% 43

Other funds holding ALKS

Soleus Capital Management's ALKS Position: Q2 2026 in Review

Soleus Capital Management reduced its Alkermes (ALKS) stake by 48% in Q2 2026, selling an estimated $36.8M and leaving 1,029,252 shares worth $53.9M. The position accounts for 1.86% of the portfolio, ranked #14.

Soleus Capital Management first reported a position in ALKS in Q1 2023 and has held it in 6 quarters since. The position peaked at $69.7M in Q1 2026. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Soleus Capital Management held 1,029,252 shares of Alkermes worth $53.9M as of Q2 2026.
  • Soleus Capital Management sold 941,612 Alkermes shares in Q2 2026, an estimated $36.8M.
  • Alkermes made up 1.86% of Soleus Capital Management's portfolio in Q2 2026, its #14 holding.
  • Soleus Capital Management first reported a position in Alkermes in Q1 2023 and has held it in 6 quarters since.
  • Soleus Capital Management's Alkermes position peaked at $69.7M in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.